Germany • Industry focus
3

Healthcare and life sciences

logo

Dentons

More information
Dentons comprehensively advises across the healthcare sector and supports physician and pharmacy associations, hospital groups, financial investors as well as medical device, pharmaceutical and biotechnology companies. The practice focuses on corporate law and transaction-related matters as well as contractual and regulatory advice, with most recent instructions pertaining to medicinal cannabis. Practice head Ilka Mehdorn boasts regulatory expertise and advises on selective, distribution and research-related contracts, she also regularly leads in proceedings before arbitration tribunals and courts.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'Great competence in all areas.'

  • 'Extremely extensive experience, competence and knowledge, very pleasant to work with.'

  • 'The Dentons team has a very broad range of experience, from corporate law, contract management, license management, restructuring and market law (antitrust law, approvals) as well as IP, trademark law and tax law. This knowledge always allows for a comprehensive, holistic advisory approach, so that a solution with various options is always proposed for implementation. Individual elements are worked out quickly and with high quality.'

  • 'Thomas Strassner is particularly distinguished by his efforts to find viable and sensible solutions. Difficult legal situations are explained in an understandable way and prepared in such a way that management can make a responsible decision. This leads to efficiency, effectiveness and the sensible use of resources.'

Key clients

  • DEMECAN GmbH
  • atai Life Sciences
  • BARMER
  • Bayer AG
  • BG Kliniken Ludwigshafen und Tübingen gGmbH
  • BG Kliniken - Klinikverbund der gesetzlichen Unfallversicherung gGmbH
  • CherryHUB
  • TVM Life Sciences
  • Klinikum Darmstadt
  • Novartis AG

Work highlights

Advice and preparation of two legal opinions for DEMECAN GmbH on the legalisation of cannabis.
Advising Novartis AG in criminal and civil proceedings in connection with pharmaceutical crime, including trademark and patent infringement, valued at €20 million.
Advising TVM Capital Life Science on the Series A financing round for Myosotis GmbH, including an investment of €8 million to support growth and development of new modules.

Lawyers

Practice head

Ilka Mehdorn

Other key lawyers

Peter Homberg; Thomas Strassner; Christof Kautzsch